Group 1 - The company expects a net profit attributable to shareholders for 2025 to be between 530 million to 630 million yuan, representing an increase of 278.66 million to 378.66 million yuan compared to the previous year, with a year-on-year growth of 110.87% to 150.66% [2][4] - The company anticipates a net profit attributable to shareholders after deducting non-recurring gains and losses for 2025 to be between 524 million to 624 million yuan, which is an increase of 278.19 million to 378.19 million yuan year-on-year, reflecting a growth of 113.17% to 153.86% [2][4] Group 2 - The performance forecast period is from January 1, 2025, to December 31, 2025 [3] - The previous year's net profit attributable to shareholders was 251.34 million yuan, and the net profit after deducting non-recurring gains and losses was 245.81 million yuan [6] Group 3 - The main reasons for the profit increase include the sustained high prosperity of the refrigerant industry, with price increases driving profit growth. The supply-demand dynamics are expected to remain favorable, with a continued reduction in production quotas for second-generation and third-generation refrigerants [8] - The company benefits from a complete industrial chain layout, which enhances operational efficiency and cost control, while its technological advantages in fluorinated polymer materials continue to translate into competitive products, improving market competitiveness and profitability [9]

中访网数据 中信银行股份有限公司于2026年1月14日发布了2025年度业绩快报。报告显示，2025年度， 该行实现营业总收入2,124.75亿元，较上年微降0.55%；实现归属于本行股东的净利润706.18亿元，同比 增长2.98%，盈利能力保持稳健。资产规模方面，截至2025年末，中信银行总资产达101,316.58亿元， 较上年末增长6.28%，首次突破10万亿元大关；归属于本行普通股股东的所有者权益为7,238.61亿元， 增长5.78%。资产质量保持稳定，不良贷款率为1.15%，较上年末下降0.01个百分点；拨备覆盖率为 203.61%，较上年末下降5.82个百分点。公告指出，面对复杂环境，该行坚持服务实体经济，战略转型 取得积极进展。本次披露数据为初步核算的集团口径数据，未经审计，最终数据以年度报告为准。 ...

Core Viewpoint - In 2025, CITIC Bank reported a net profit of 70.618 billion RMB, reflecting a year-on-year growth of 2.98%, despite a slight decline in total operating revenue by 0.55% to 212.475 billion RMB [3]. Financial Data and Indicators - Basic earnings per share and weighted average return on equity are calculated according to the relevant regulations [2]. - The bank issued dividends of 1.428 billion RMB for preferred shares in October 2025, which impacted the earnings per share and return on equity calculations [2]. - The issuance of perpetual bonds in April 2025 resulted in interest payments totaling 2.406 billion RMB, also affecting the financial metrics [2]. - A convertible bond issued in 2019 matured in March 2025, converting approximately 39.943 billion RMB into common shares, with a total of 6.710 billion shares converted [2]. Operating Performance and Financial Condition - CITIC Bank's total assets reached 10,131.658 billion RMB by the end of 2025, marking a growth of 6.28% from the previous year [3]. - The equity attributable to ordinary shareholders increased by 5.78% to 723.861 billion RMB [3]. - The non-performing loan ratio was reported at 1.15%, a slight decrease of 0.01 percentage points from the previous year [3]. - The provision coverage ratio stood at 203.61%, down by 5.82 percentage points compared to the end of the previous year [3].

Major Events - Longi Technology (09611) plans to globally offer 52.2591 million H-shares from January 14 to January 19 [1] - CK Life Sciences (00013) announced the results of the SACHI III study published in The Lancet [1] - Dongyang Sunshine Pharmaceutical (06887) launched an AI-driven R&D platform targeting the PROTAC mechanism, continuing to deepen its AI strategic layout [1] - Dongyao Pharmaceutical-B (01875) received a cash offer from WuXi AppTec (02268) at a premium of approximately 99%, with resumption of trading on January 15 [1] - Valiant Pharmaceuticals-B (09887) received Fast Track designation from the US FDA for its bispecific antibody, Opalizumab (LBL-024) [1] - Xunqi (03317) entered into a strategic cooperation framework agreement with Jinyong Investment to support digital transformation in investment research, trading, and risk management [1] Operating Performance - CITIC Securities (06030) reported a net profit attributable to shareholders of 30.051 billion yuan for 2025, an increase of 38.46% year-on-year [1] - CITIC Bank (00998) reported a net profit attributable to shareholders of 70.618 billion yuan for 2025, a year-on-year increase of 2.98% [1] - China General Nuclear Power New Energy (01811) completed a cumulative power generation of 19,000 GWh in 2025, a decrease of 0.8% year-on-year [1] - Yuexiu Property (00123) reported a cumulative contract sales amount of approximately 106.21 billion yuan for 2025 [1] - WuXi AppTec (02268) issued a profit warning, expecting a net profit growth of over 38% year-on-year for 2025 [1] - Jinyu Group (02009) issued a profit warning, anticipating a net loss attributable to shareholders of 900 million to 1.2 billion yuan for 2025 [1] - Saijing Technology (00580) issued a profit alert, expecting a net profit increase of approximately 30.0% for 2025 [1] - Beijing Beichen Industrial Co., Ltd. (00588) issued a profit warning, expecting a net loss attributable to shareholders of 2.696 billion to 3.38 billion yuan for 2025 [1]

Group 1 - The stock price of Shangwei New Materials has significantly increased since July 2025, leading to abnormal trading fluctuations, and the company may apply for a trading suspension if the price continues to rise [1] - CITIC Securities reported a net profit of 30.05 billion yuan for 2025, a year-on-year increase of 38.46%, driven by growth in brokerage, investment banking, and proprietary trading [2] - Huibo Technology's controlling shareholder will change to Tianjin State-owned Assets Supervision and Administration Commission after transferring 341 million shares, representing 25.60% of the total share capital [3] Group 2 - Caixun Co. plans to issue convertible bonds to raise up to 1.46 billion yuan for projects including the construction of an intelligent computing center and AI application development [4] - Jinhaitong expects a net profit of 160 to 210 million yuan for 2025, a year-on-year increase of 103.87% to 167.58%, due to rising demand in the semiconductor packaging sector [5] - Aoyuan Ceiling announced that it may apply for a trading suspension if its stock price continues to rise significantly [6] Group 3 - Yanshan Technology's commercialization of brain-machine interface and brain-like intelligence business is still in the early stages, with no revenue generated yet [7] - Haige Communication expects a net loss for 2025 due to industry client adjustments and increased investment in innovative businesses [9] - Hu Silicon Industry anticipates a net loss of 1.28 to 1.53 billion yuan for 2025, with a significant increase in losses compared to the previous year [10] Group 4 - Guangyun Technology may apply for a trading suspension if its stock price continues to rise abnormally [11] - Wenkang Development plans to swap its main assets and liabilities with 100% equity of Wenkang Mining and Luzhong Mining, facilitating a business transformation [12] - Jinqiao Information clarified that its AI-related judicial business is not its main business and does not significantly impact overall performance [13] Group 5 - Yonghe Co. expects a net profit increase of 110.87% to 150.66% for 2025, while CITIC Bank anticipates a 2.98% increase in net profit to 70.62 billion yuan [14] - Guotou Power's power generation volume decreased by 8.12% year-on-year for 2025, while Jiamei Packaging expects a net profit decrease of 43% to 53% [14] - Shengke Communication anticipates a net loss of 120 to 160 million yuan for 2025 [14]

（文章来源：证券日报） 证券日报网讯 1月14日，富恒新材发布公告称，公司第五届董事会第九次会议审议通过《关于公司向中 信银行股份有限公司深圳分行申请综合授信额度的议案》《关于关联方无偿为公司向中信银行股份有限 公司深圳分行申请综合授信额度提供连带责任保证担保的议案》《关于子公司为公司向中信银行股份有 限公司深圳分行申请综合授信额度提供保证担保的议案》等多项议案。 ...

今日晚间重要公告抢先看——利欧股份称目前经营情况正常，不存在公司应披露而未披露的重大事项； 中文在线称公司主营业务目前不涉及GEO；引力传媒称若公司股价进一步上涨，可能申请停牌核查。 【重大事项】 利欧股份：目前经营情况正常 不存在公司应披露而未披露的重大事项 1月14日，利欧股份(002131.SZ)公告称，公司股票价格于2026年1月13日、2026年1月14日连续两个交易 日收盘价格涨幅偏离值累计超过20%，属于股票交易异常波动的情况。经核实，公司前期披露的信息不 存在需要更正、补充之处，近期经营情况正常，内外部经营环境未发生重大变化，公司及控股股东、实 际控制人不存在关于公司的应披露而未披露的重大事项，或处于筹划阶段的重大事项。 泓博医药：现阶段DiOrion平台药物研发服务直接收入占整体营业收入的比重较小 1月14日，泓博医药(301230.SZ)发布股票交易异常波动及股票交易严重异常波动公告称，现阶段公司 DiOrion平台药物研发服务的直接收入占公司整体营业收入的比重较小，对公司整体经营情况不构成重 大影响。经自查，公司未发现近期公共传媒报道了可能或已经对公司股票交易价格产生较大影响的未公 开重 ...

（文章来源：证券日报） 证券日报网讯 1月14日，中信银行发布2025年度业绩快报公告称，公司2025年度实现营业总收入2， 124.75亿元，同比下降0.55%；归属于本行股东的净利润706.18亿元，同比增长2.98%。 ...

资产质量方面，截至2025年末，中信银行不良贷款率1.15%，比上年末下降0.01个百分点；拨备覆盖率 203.61%，比上年末下降5.82个百分点。 资产规模方面，截至2025年末，中信银行资产总额站上十万亿元，达到101316.58亿元，比上年末增长 6.28%；归属于该行普通股股东的所有者权益 7238.61亿元，比上年末增长5.78%。 值得一提的是，在银行业息差普遍收窄、盈利承压的大环境下，中信银行近年净利润始终保持正增长。 财报数据显示，2021年至2024年，该行净利润增速分别为13.60%、11.61%、7.91%、2.33%。在2025年 半年度业绩发布会上，中信银行原行长芦苇曾感慨道，"一个故事讲一年不难，但是持续讲，而且要讲 好，可不容易。"他还表示，中信银行是自上市以来极少数每年都实现利润正增长的股份行。 2025年12月30日晚，中信银行发布公告称，芦苇因工作调整，辞去该行行长等职务，由董事长方合英代 为履行行长职责。根据邮储银行此前发布的公告，芦苇获聘邮储银行行长。这家十万亿级股份行的新行 长人选，成为市场关注焦点。 4家股份行进入十万亿阵营 "十万亿银行圈"再添新成员！1月14日 ...

Company News - CITIC Securities (06030.HK) reported a revenue of RMB 74.83 billion for the fiscal year 2025, representing a year-on-year increase of 28.75%, and a net profit of RMB 30.05 billion, up 38.46% year-on-year [2] - CITIC Bank (00998.HK) announced a total revenue of RMB 212.48 billion for 2025, a slight decrease of 0.55% year-on-year, while net profit increased by 2.98% to RMB 70.62 billion [2] - Beijing North Star Industrial (00588.HK) expects to continue reporting losses for the fiscal year ending December 31, 2025 [3] - Yuexiu Property (00123.HK) reported a cumulative contract sales amount of approximately RMB 106.21 billion for 2025, a decline of about 7.3% year-on-year, achieving 88.1% of its sales target [3] - Jiao Ge Peng You Holdings (01450.HK) achieved a total GMV of approximately RMB 6.49 billion in Q4 2025, a year-on-year increase of about 4.34%, with a cumulative GMV of RMB 16.02 billion for the year, up 6.23% [3] - Sai Jing Technology (00580.HK) anticipates a revenue of approximately RMB 2.25 billion for 2025, reflecting a year-on-year increase of about 40% due to increased revenue from flexible transmission business [3] - China General Nuclear Power New Energy (01811.HK) reported a cumulative power generation of 19,000 GWh for 2025, a decrease of 0.8% year-on-year, with variations in different energy sources [3] - Morning News Technology (02000.HK) reported an unaudited revenue of HKD 397 million for 2025, a decrease of 7.4% year-on-year [3] Financing and Buyback Activities - Chow Tai Fook Enterprises (00659.HK) applied for the registration of debt financing instruments totaling no more than RMB 5 billion [7] - Tencent Holdings (00700.HK) repurchased 1.006 million shares at a cost of approximately HKD 636 million, with repurchase prices ranging from HKD 626 to HKD 638 [7] - Xiaomi Group-W (01810.HK) repurchased 4 million shares for approximately HKD 151 million, with repurchase prices between HKD 37.61 and HKD 42.50 [7] Research and Development - Hutchison China MediTech (00013.HK) announced the publication of SACHI III study results in The Lancet [4] - Laka Pharmaceuticals-B (02105.HK) had its clinical trial application for the new drug LAE118 accepted by the U.S. FDA [5] Other News - Yuanxu Technology (08637.HK) announced a short suspension of trading starting January 14, pending the release of insider information [6] - Haidilao (06862.HK) redeemed USD 600 million of its 2.150% notes due in 2026 [2]